Table 1.
Group | n | Mean | SD | t-test |
Odds ratio for abnormal/below-normal values |
|||
---|---|---|---|---|---|---|---|---|
Value |
95% CI |
|||||||
Lower | Upper | |||||||
Total cholesterol (serum) | Cases | 226 | 205.075 | 49.574 | 2.755 | 0.505 | 0.335 | 0.761 |
Controls | 164 | 192.634 | 34.956 | p = 0.006 HS | ||||
Triglycerides | Cases | 226 | 161.867 | 140.419 | 3.555 | 0.447 | 0.285 | 0.701 |
Controls | 164 | 120.268 | 61.231 | p < 0.001 VHS | ||||
HDL cholesterol | Cases | 226 | 44.648 | 11.211 | 4.089 | 0.593 | 0.384 | 0.916 |
Controls | 164 | 50.063 | 14.946 | p < 0.001 VHS | ||||
LDL cholesterol | Cases | 226 | 146.944 | 38.539 | 3.173 | 0.938 | 0.523 | 1.684 |
Controls | 164 | 135.074 | 33.387 | p = 0.002 HS | ||||
GOT (AST) | Cases | 167 | 28.371 | 17.102 | 2.295 | 0.352 | 0.129 | 0.959 |
Controls | 94 | 23.968 | 9.725 | p = 0.023 SIG | ||||
GPT (ALT) | Cases | 169 | 39.373 | 24.614 | 2.326 | 0.564 | 0.321 | 0.992 |
Controls | 97 | 32.361 | 21.898 | p = 0.021 SIG | ||||
HbA1c | Cases | 174 | 6.483 | 1.506 | 3.419 | 0.379 | 0.232 | 0.618 |
Controls | 137 | 5.951 | 1.152 | p < 0.001 VHS |
SD, standard deviation; CI, confidence interval; HDL, high-density lipoprotein; LDL, low-density lipoprotein; GOT, glutamic oxaloacetic transaminase; GPT, glutamic pyruvic transaminase; HbA1c, glycosylated hemoglobin; VHS, very highly significant; HS, highly significant; SIG, significant.